Pivotal Role for Cxcr2 in Regulating Tumor-Associated Neutrophil in Breast Cancer

被引:27
作者
Timaxian, Colin [1 ,2 ]
Vogel, Christoph F. A. [3 ]
Orcel, Charlotte [1 ]
Vetter, Diana [1 ]
Durochat, Camille [1 ]
Chinal, Clarisse [1 ]
Nguyen, Phuong [1 ]
Aknin, Marie-Laure [4 ]
Mercier-Nome, Francoise [4 ]
Davy, Martin [1 ]
Raymond-Letron, Isabelle [5 ,6 ]
Van, Thi-Nhu-Ngoc [1 ]
Diermeier, Sarah D. [7 ]
Godefroy, Anastasia [8 ]
Gary-Bobo, Magali [8 ]
Molina, Franck [1 ]
Balabanian, Karl [2 ,9 ]
Lazennec, Gwendal [1 ,2 ]
机构
[1] CNRS, SYS2DIAG ALCEDIAG, 1682 Rue Valsiere, F-34184 Montpellier, France
[2] CNRS, GDR Microenvironm Tumor Niches 3697, Micronit, France
[3] Univ Calif Davis, Ctr Hlth & Environm, 1 Shields Ave, Davis, CA 95616 USA
[4] Univ Paris Saclay, CNRS, Inst Paris Saclay Innovat Therapeut, INSERM, F-92296 Chatenay Malabry, France
[5] Natl Vet Sch Toulouse, Dept Histopathol, F-31076 Toulouse, France
[6] CNRS, UMR UPS 5223, Platform Expt & Compared Histopathol, EFS,INSERM,U1031, F-31076 Toulouse, France
[7] Univ Otago, Dept Biochem, Dunedin 9016, New Zealand
[8] Univ Montpellier, CNRS, IBMM, ENSCM, F-34093 Montpellier, France
[9] Univ Paris, Inst Rech St Louis, EMiLy, INSERM,U1160, F-75010 Paris, France
关键词
chemokine receptors; breast cancer; Cxcr2; neutrophils; tumor microenvironment; COLONY-STIMULATING FACTOR; SUPPRESSOR-CELLS; MAMMARY-TUMORS; BONE-MARROW; MOUSE MODEL; STEM-CELLS; EXPRESSION; GROWTH; ANGIOGENESIS; RECEPTOR;
D O I
10.3390/cancers13112584
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Chemokines present in the tumor microenvironment are essential for the control of tumor progression. We show here that the knock-down of Cxcr2 in PyMT animals led to an increased growth of the primary tumor and lung metastasis. The analysis of tumor content of PyMT-Cxcr2-/- animals highlighted an increased infiltration of tumor associated neutrophils (TANs), mirrored by a decreased recruitment of tumor associated macrophages (TAMs) compared to PyMT animals. Analysis of PyMT-Cxcr2-/- TANs revealed that they lost their killing ability compared to PyMT-Cxcr2+/+ TANs and that they had a more pronounced pro-tumor TAN2 profile compared to PyMT TANs. PyMT-Cxcr2-/- TANs displayed an up-regulation of the pathways involved in reactive oxygen species (ROS) production and angiogenesis and factors favoring metastasis, but reduced apoptosis. In summary, our data reveal that a lack of Cxcr2 provides TANs with pro-tumor effects. Chemokines present in the tumor microenvironment are essential for the control of tumor progression. We show here that several ligands of the chemokine receptor Cxcr2 were up-regulated in the PyMT (polyoma middle T oncogene) model of breast cancer. Interestingly, the knock-down of Cxcr2 in PyMT animals led to an increased growth of the primary tumor and lung metastasis. The analysis of tumor content of PyMT-Cxcr2-/- animals highlighted an increased infiltration of tumor associated neutrophils (TANs), mirrored by a decreased recruitment of tumor associated macrophages (TAMs) compared to PyMT animals. Analysis of PyMT-Cxcr2-/- TANs revealed that they lost their killing ability compared to PyMT-Cxcr2+/+ TANs. The transcriptomic analysis of PyMT-Cxcr2-/- TANs showed that they had a more pronounced pro-tumor TAN2 profile compared to PyMT TANs. In particular, PyMT-Cxcr2-/- TANs displayed an up-regulation of the pathways involved in reactive oxygen species (ROS) production and angiogenesis and factors favoring metastasis, but reduced apoptosis. In summary, our data reveal that a lack of Cxcr2 provides TANs with pro-tumor effects.
引用
收藏
页数:20
相关论文
共 86 条
  • [1] A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
    Acharyya, Swarnali
    Oskarsson, Thordur
    Vanharanta, Sakari
    Malladi, Srinivas
    Kim, Juliet
    Morris, Patrick G.
    Manova-Todorova, Katia
    Leversha, Margaret
    Hogg, Nancy
    Seshan, Venkatraman E.
    Norton, Larry
    Brogi, Edi
    Massague, Joan
    [J]. CELL, 2012, 150 (01) : 165 - 178
  • [2] Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment
    Acuff, HB
    Carter, KJ
    Fingleton, B
    Gorden, DL
    Matrisian, LM
    [J]. CANCER RESEARCH, 2006, 66 (01) : 259 - 266
  • [3] The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
    Addison, CL
    Daniel, TO
    Burdick, MD
    Liu, H
    Ehlert, JE
    Xue, YY
    Buechi, L
    Walz, A
    Richmond, A
    Strieter, RM
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (09) : 5269 - 5277
  • [4] Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics
    Alshetaiwi, Hamad
    Pervolarakis, Nicholas
    McIntyre, Laura Lynn
    Ma, Dennis
    Quy Nguyen
    Rath, Jan Akara
    Nee, Kevin
    Hernandez, Grace
    Evans, Katrina
    Torosian, Leona
    Silva, Anushka
    Walsh, Craig
    Kessenbrock, Kai
    [J]. SCIENCE IMMUNOLOGY, 2020, 5 (44)
  • [5] Type I IFNs induce anti-tumor polarization of tumor associated neutrophils in mice and human
    Andzinski, Lisa
    Kasnitz, Nadine
    Stahnke, Stephanie
    Wu, Ching-Fang
    Gereke, Marcus
    von Koeckritz-Blickwede, Maren
    Schilling, Bastian
    Brandau, Sven
    Weiss, Siegfried
    Jablonska, Jadwiga
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (08) : 1982 - 1993
  • [6] Delayed apoptosis of tumor associated neutrophils in the absence of endogenous IFN-β
    Andzinski, Lisa
    Wu, Ching-Fang
    Lienenklaus, Stefan
    Kroeger, Andrea
    Weiss, Siegfried
    Jablonska, Jadwiga
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (03) : 572 - 583
  • [7] CXC chemokines located in the 4q21 region are up-regulated in breast cancer
    Bieche, Ivan
    Chavey, Carine
    Andrieu, Catherine
    Busson, Muriel
    Vacher, Sophie
    Le Corre, Ludovic
    Guinebretiere, Jean-Marc
    Burlinchon, Sandrine
    Lidereau, Rosette
    Lazennec, Gwendal
    [J]. ENDOCRINE-RELATED CANCER, 2007, 14 (04) : 1039 - 1052
  • [8] Abrogation of TGF-β signaling enhances chemokine production and correlates with prognosis in human breast cancer
    Bierie, Brian
    Chung, Christine H.
    Parker, Joel S.
    Stover, Daniel G.
    Cheng, Nikki
    Chytil, Anna
    Aakre, Mary
    Shyr, Yu
    Moses, Harold L.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (06) : 1571 - 1582
  • [9] Understanding the tumor immune microenvironment (TIME) for effective therapy
    Binnewies, Mikhail
    Roberts, Edward W.
    Kersten, Kelly
    Chan, Vincent
    Fearon, Douglas F.
    Merad, Miriam
    Coussens, Lisa M.
    Gabrilovich, Dmitry I.
    Ostrand-Rosenberg, Suzanne
    Hedrick, Catherine C.
    Vonderheide, Robert H.
    Pittet, Mikael J.
    Jain, Rakesh K.
    Zou, Weiping
    Howcroft, T. Kevin
    Woodhouse, Elisa C.
    Weinberg, Robert A.
    Krummel, Matthew F.
    [J]. NATURE MEDICINE, 2018, 24 (05) : 541 - 550
  • [10] Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
    Biswas, Subhra K.
    Mantovani, Alberto
    [J]. NATURE IMMUNOLOGY, 2010, 11 (10) : 889 - 896